StreetAlpha.app
Home › Stocks › ACH

Accendra Health Inc (ACH)

$0.09
▼ −35.08%
LAST CLOSE · NOV 16

Accendra Health supplies home healthcare equipment, medical supplies and related services to patients and home health agencies. It last closed at $0.09 on Nov 16, down 35.08% on the day. The next earnings report for ACH is expected around Thu, Feb 18, 2027, after the close. For the quarter ended Sep 2026, ACH reported EPS of -$0.25 on revenue of $601.8M, with revenue down 13.7% from a year ago. Over its last 4 reports the stock moved an average of 23.9% the session after earnings. Over the last 12 months ACH insiders bought $0 of stock on the open market and sold $4K, according to SEC Form 4 filings.

AI Auto Pilots
Is ACH in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ACH.

Key Stats

Last 12 months
Results
Revenue
$2.6B
−7.1% vs a year ago
Net income
−$171.6M
−6.7% margin
EPS (diluted)
−$2.26
Gross margin
44.1%
$1.1B gross profit
Valuation
Market cap
$6.6M
76.9M shares
P/E
–
No P/E while losing money
Price to sales
0.0
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$26.6M
At Sep 30
Shareholder equity
−$568.2M
Shares outstanding
76.9M
At Sep 30
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $9.8B$9.8BFY2021FY2022: $10.0B$10.0BFY2022FY2023: $2.6B$2.6BFY2023FY2024: $2.7B$2.7BFY2024FY2025: $2.8B$2.8BFY2025

From ACH's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 6). Last 12 months adds up the four latest quarters.

Next report
Feb 18
Estimated date · After the close
Reported EPS
-$0.25
Quarter ended Sep 2026
Year ago EPS
-$1.94
Same quarter last year
Revenue
$601.8M
−13.7% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$3.86Dec '24Mar 2025: -$0.32Mar '25Jun 2025: -$11.30Jun '25Sep 2025: -$1.94Sep '25Dec 2025: -$0.76Dec '25Mar 2026: -$0.08Mar '26Jun 2026: -$1.16Jun '26Sep 2026: -$0.25Sep '26Latest -$0.25
Revenue by quarter
Dec 2024: $695.0MDec '24Mar 2025: $673.9MMar '25Jun 2025: $681.9MJun '25Sep 2025: $697.3MSep '25Dec 2025: $709.0MDec '25Mar 2026: $627.8MMar '26Jun 2026: $613.2MJun '26Sep 2026: $601.8MSep '26Latest $601.8M
How ACH moved after its last 4 reports
Average move the session after a report ±23.9%
Nov 5, 2026After the close−31.9%
Aug 10, 2026Time not announced−50.0%
May 11, 2026Time not announced+8.7%
Feb 19, 2026After the close+5.2%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on ACHStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on ACH
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on ACH

Technical Analysis

ACH · as of the Nov 16 close · updated each morning
Downtrend, oversold

The stock is 145% below its 20 day and 473% below its 50 day average. It is 2384% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 20), oversold. The nearest support is the 52 week low at $0.08, and the nearest resistance the Pivot at $0.10.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 58.4%/day
Key levels
$4.6952 week high+5111.1%
$2.13200 day average+2266.7%
$1.48100 day average+1544.4%
$0.4950 day average+444.4%
$0.33Swing high (Nov 2)+266.7%
$0.2120 day average+133.3%
$0.12Pivot R1+33.3%
$0.10Pivot+11.1%
$0.09Last close
$0.0852 week low−11.1%
$0.07Pivot S1−22.2%
Indicators
RSI (14)20.00Oversold below 30Oversold
MACD-0.10Above its signal lineBullish
Stochastic4.7Near the bottom of its rangeOversold
ADX (14)51.0Strong downtrend
Williams %R-98.4Oversold below −80, overbought above −20Oversold
CCI (20)-180.1Oversold below −100, overbought above 100Oversold
Rate of change−67.5%Change over 10 sessionsBearish
ATR (14)$0.05Typical daily range, 58.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for ACH

What happened before

See how ACH did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow ACH usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How ACH has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for ACHHow many large options trades hit ACH, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

ACH Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bearish
Strongly bearishNeutralStrongly bullish
  • ▼42 buying vs 89 selling
  • ▼Held by funds -1.4 pts
  • ▼Funds holding -25
  • ▼Superinvestors: 1 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding117142−17.6%
In funds' top 10110.0%
Held by funds79.7%81.1%−1.4 pts
New / increased17 / 2520 / 43−33.3%
Reduced / sold out47 / 4245 / 21+34.8%
Put/call ratio0.000.00–
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See ACH institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

ACH Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$4K1 sale · 1 insider
100% of the selling was under pre-arranged trading plans.
2026-11 sold $4KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 16Perry A Bernocchiformer Chief Operating OfficerSale plan33,161$0.12$4K
Aug 14, 2025Coliseum Capital Partners, L.P.10% ownerBuy1,537,852$5.27$8.1M
Apr 10, 2025Coliseum Capital, LLC10% ownerBuy410,000$7.50$3.1M
Apr 7, 2025Coliseum Capital Management, LLC10% ownerBuy528,356$8.12$4.3M
Mar 4, 2025Christopher S Shackelton10% ownerBuy2,893,412$9.46$27.4M
Nov 21, 2024Jonathan A LeonEvp, CFOSale plan5,282$11.82$62K
Every insider buy and sale for ACH over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See ACH insider trades →

From SEC Form 4 filings by ACH's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ACH is in one of them and how their past ACH trades turned out.

ACH in the AI portfolios
Loading…

ACH News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered ACH in an article yet. Here's the latest on the wider market.

ACH in the news

About Accendra Health

Accendra Health provides home healthcare equipment, medical supplies and related services for patients who receive care in their homes. Its product lines cover diabetes care, home respiratory therapy, sleep apnea devices, ostomy, wound care, urology and incontinence products. The company rents and sells these items directly to patients and home health agencies, and it is paid by managed care plans, Medicare, Medicaid and private insurers. It is based in Virginia and sells under the Apria and Byram Healthcare brands.

Headquarters
Glen Allen, VA
Founded
1882